Gossamer Bio Inc (NASDAQ: GOSS)’s stock price has dropped by -9.20 in relation to previous closing price of 1.08. Nevertheless, the company has seen a loss of -14.73% in its stock price over the last five trading days. Zacks Investment Research reported 2024-03-07 that Gossamer Bio, Inc. (GOSS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GOSS’s 50-day simple moving average broke out above its 200-day moving average; this is known as a “golden cross.
Is It Worth Investing in Gossamer Bio Inc (NASDAQ: GOSS) Right Now?
GOSS has 36-month beta value of 1.75. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GOSS is 188.84M, and currently, short sellers hold a 5.87% ratio of that float. The average trading volume of GOSS on April 09, 2024 was 1.22M shares.
GOSS’s Market Performance
GOSS stock saw a decrease of -14.73% in the past week, with a monthly decline of -28.94% and a quarterly a decrease of 6.59%. The volatility ratio for the week is 8.26%, and the volatility levels for the last 30 days are 8.13% for Gossamer Bio Inc (GOSS). The simple moving average for the past 20 days is -22.85% for GOSS’s stock, with a -2.97% simple moving average for the past 200 days.
Analysts’ Opinion of GOSS
Many brokerage firms have already submitted their reports for GOSS stocks, with Wedbush repeating the rating for GOSS by listing it as a “Outperform.” The predicted price for GOSS in the upcoming period, according to Wedbush is $4 based on the research report published on April 05, 2024 of the current year 2024.
UBS, on the other hand, stated in their research note that they expect to see GOSS reach a price target of $1.25, previously predicting the price at $8. The rating they have provided for GOSS stocks is “Neutral” according to the report published on July 27th, 2023.
GOSS Trading at -16.08% from the 50-Day Moving Average
After a stumble in the market that brought GOSS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.84% of loss for the given period.
Volatility was left at 8.13%, however, over the last 30 days, the volatility rate increased by 8.26%, as shares sank -24.63% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +26.23% upper at present.
During the last 5 trading sessions, GOSS fell by -12.17%, which changed the moving average for the period of 200-days by -25.19% in comparison to the 20-day moving average, which settled at $1.2545. In addition, Gossamer Bio Inc saw 7.46% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GOSS starting from Hasnain Faheem, who sale 23,172 shares at the price of $1.16 back on Mar 27 ’24. After this action, Hasnain Faheem now owns 120,293 shares of Gossamer Bio Inc, valued at $26,773 using the latest closing price.
Giraudo Bryan, the COO/CFO of Gossamer Bio Inc, sale 6,430 shares at $1.16 during a trade that took place back on Mar 27 ’24, which means that Giraudo Bryan is holding 92,737 shares at $7,431 based on the most recent closing price.
Stock Fundamentals for GOSS
The total capital return value is set at -0.67. Equity return is now at value -480.50, with -61.54 for asset returns.
Based on Gossamer Bio Inc (GOSS), the company’s capital structure generated 0.77 points at debt to capital in total, while cash flow to debt ratio is standing at -0.75. The debt to equity ratio resting at 3.38. The interest coverage ratio of the stock is -12.86.
Currently, EBITDA for the company is -169.37 million with net debt to EBITDA at -1.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.94.
Conclusion
To put it simply, Gossamer Bio Inc (GOSS) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
